Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Development of Blood Vessels01:07

Development of Blood Vessels

562
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
562
Cleavage and Blastulation01:33

Cleavage and Blastulation

45.0K
After a large-single-celled zygote is produced via fertilization, the process of cleavage occurs while zygotes travel through the uterine tube. Cleavage is a mitotic cell division that does not result in growth. With each round of successive cell division, daughter cells get increasingly smaller.
45.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Partial ectogestation and threats to the fetus: how healthcare professionals' caution may reinforce the medicalization of pregnancy and childbirth.

Journal of law and the biosciences·2025
Same author

Location, location, location: the approach of healthcare professionals in defining the artificially gestated entity.

Medical law review·2025
Same author

Editorial: In Honour of Professor Margaret Brazier: Memories of Margot.

Medical law review·2025
Same author

Respiratory Clinicians' Views on Offering "Rescue Packs" to Patients Discharged After COPD Exacerbation: Qualitative Interview Study.

COPD·2025
Same author

What Is an Identifier Good for? Issues in Using Visual Identifiers to Improve Care for People With Dementia in Hospital.

Journal of advanced nursing·2025
Same author

Legal fictions and complex lived realities: attributing legal parenthood in P V Q & F & X [2024] EWFC 85 (B)(FAM).

Medical law review·2025
Same journal

Biobanks as fiduciaries of biosamples and data: a legal and ethical analysis in the light of international standards.

Journal of law and the biosciences·2026
Same journal

Chat M.D.

Journal of law and the biosciences·2026
Same journal

Regulating genetic discrimination in Chinese employment: insights from thalassemia-related cases.

Journal of law and the biosciences·2026
Same journal

Still invisible? Legal and ethical treatment of intersex individuals in China.

Journal of law and the biosciences·2026
Same journal

The SNP consortium: background and context.

Journal of law and the biosciences·2026
Same journal

Two-faced Janus? Consent to participate in research and consent to data processing in the EHDS era: a comparative analysis of requirements and standards in eight European countries.

Journal of law and the biosciences·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2025

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.6K

Death and the artificial placenta.

Anna Nelson1, Elizabeth Chloe Romanis2,3, Victoria Adkins4

  • 1School of Law, University of Sheffield, Sheffield, S3 7ND, UK.

Journal of Law and the Biosciences
|July 17, 2024
PubMed
Summary
This summary is machine-generated.

Artificial Amnion and Placenta Technology (AAPT) offers an artificial womb for premature fetuses. Current UK law struggles to define death for entities sustained by AAPT, causing legal ambiguity for grieving parents.

Keywords:
artificial placentaartificial wombdeathmiscarriagestillbirth

More Related Videos

Ex Vivo Perfusion of the Rodent Placenta
06:54

Ex Vivo Perfusion of the Rodent Placenta

Published on: May 30, 2019

9.8K
Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
08:08

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model

Published on: June 18, 2013

17.3K

Related Experiment Videos

Last Updated: Jun 21, 2025

Mouse In Vivo Placental Targeted CRISPR Manipulation
07:39

Mouse In Vivo Placental Targeted CRISPR Manipulation

Published on: April 14, 2023

2.6K
Ex Vivo Perfusion of the Rodent Placenta
06:54

Ex Vivo Perfusion of the Rodent Placenta

Published on: May 30, 2019

9.8K
Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
08:08

Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model

Published on: June 18, 2013

17.3K

Area of Science:

  • Bioethics
  • Medical Law
  • Reproductive Technology

Background:

  • Artificial Amnion and Placenta Technology (AAPT), or 'artificial womb technology,' enables continued fetal development outside the human uterus.
  • As AAPT nears human application, its ethical and legal implications require urgent clarification.

Purpose of the Study:

  • To explore the legal characterization of death for an entity sustained by AAPT.
  • To identify challenges in applying existing legal frameworks to AAPT-sustained entities.

Main Methods:

  • Analysis of existing legal criteria for death determination in England and Wales, particularly for pre-term or neonatal cases.
  • Examination of the applicability of these criteria to entities within an AAPT system.

Main Results:

  • Current legal criteria in England and Wales are insufficient to definitively characterize death in the context of AAPT.
  • Significant challenges arise when attempting to apply existing legal frameworks to AAPT-sustained entities.

Conclusions:

  • The legal framework in England and Wales may be inadequate for addressing the complexities of death determination with AAPT.
  • Legal ambiguity surrounding death in AAPT could exacerbate parental suffering and uncertainty.